Title:
PREDICTION METHOD AND BIOMARKER
Document Type and Number:
WIPO Patent Application WO/2023/068220
Kind Code:
A1
Abstract:
According to the present invention, the effect of a target drug is predicted. This prediction method comprises a prediction step for predicting the effect of a drug on a disease on the basis of a value pertaining to predetermined miRNA derived from a target sample.
More Like This:
Inventors:
ZHANG YIFAN (JP)
FUJITA YU (JP)
GOTO YASUSHI (JP)
FUJITA YU (JP)
GOTO YASUSHI (JP)
Application Number:
PCT/JP2022/038566
Publication Date:
April 27, 2023
Filing Date:
October 17, 2022
Export Citation:
Assignee:
PREFERRED NETWORKS INC (JP)
International Classes:
C12N15/113; C12M1/00; C12M1/34; C12Q1/6883
Domestic Patent References:
| WO2011113030A2 | 2011-09-15 | |||
| WO2011080315A1 | 2011-07-07 |
Foreign References:
| US20110117565A1 | 2011-05-19 | |||
| US20120035068A1 | 2012-02-09 | |||
| JP2019536805A | 2019-12-19 | |||
| JP2018521976A | 2018-08-09 |
Other References:
HE QINGFANG, FANG YIRONG, LU FENG, PAN JIN, WANG LIXIN, GONG WEIWEI, FEI FANGRONG, CUI JINGJIE, ZHONG JIEMING, HU RUYING, LIANG MI: "Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer", JOURNAL OF CLINICAL LABORATORY, vol. 33, no. 9, 1 November 2019 (2019-11-01), US , XP093059518, ISSN: 0887-8013, DOI: 10.1002/jcla.23003
HSU YA-LING, HUNG JEN-YU, CHEN FENG-WEI, CHANG KUO-FENG, CHANG WEI-AN, TSAI YING-MING, CHONG INN-WEN, KUO PO-LIN: "Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis", ONCOTARGET, vol. 8, no. 62, 1 January 2017 (2017-01-01), pages 104831 - 104854, XP093059520
JU LIXIA, HAN MINGQUAN, LI XUEFEI, ZHAO CHAO: "MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion", JOURNAL OF CANCER, vol. 8, no. 7, 1 January 2017 (2017-01-01), AU , pages 1311 - 1318, XP093059522, ISSN: 1837-9664, DOI: 10.7150/jca.17817
CHO YOON, MI-KYUNG SONG, TAE SUNG KIM & JAE-CHUN RYU: "Identification of miRNA alterations as biomarkers of particulate matter (PM) 2.5 in two model systems", TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, SPECIAL ISSUE: ABSTRACTS OF THE 10TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL HEALTH SCIENCE, vol. 9, no. 4, 1 December 2017 (2017-12-01), pages S34, XP093059537
HSU YA-LING, HUNG JEN-YU, CHEN FENG-WEI, CHANG KUO-FENG, CHANG WEI-AN, TSAI YING-MING, CHONG INN-WEN, KUO PO-LIN: "Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis", ONCOTARGET, vol. 8, no. 62, 1 January 2017 (2017-01-01), pages 104831 - 104854, XP093059520
JU LIXIA, HAN MINGQUAN, LI XUEFEI, ZHAO CHAO: "MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion", JOURNAL OF CANCER, vol. 8, no. 7, 1 January 2017 (2017-01-01), AU , pages 1311 - 1318, XP093059522, ISSN: 1837-9664, DOI: 10.7150/jca.17817
CHO YOON, MI-KYUNG SONG, TAE SUNG KIM & JAE-CHUN RYU: "Identification of miRNA alterations as biomarkers of particulate matter (PM) 2.5 in two model systems", TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, SPECIAL ISSUE: ABSTRACTS OF THE 10TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL HEALTH SCIENCE, vol. 9, no. 4, 1 December 2017 (2017-12-01), pages S34, XP093059537
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: